Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 640.83
+4.10 (0.64%)
At close: Mar 28, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 52.69 billion as of March 31, 2025. Its market cap has decreased by -35.00% in one year.
Market Cap
52.69B
Enterprise Value
41.13B
Revenue
11.34B
Ranking
n/a
PE Ratio
14.95
Stock Price
640.83
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 52.69B, an increase of 54,720.34%. That is a compound annual growth rate of 21.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.02B |
| GSK plc | 60.68B |
| Haleon | 34.51B |
| Smith & Nephew | 9.36B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.24B |